MIMEDX Provides AXIOFILL® Update & Reiterates 2023 Full
Receipt of FDA Warning Letter for AXIOFILL Classification; Not Related to Safety Request for Designation for AXIOFILL Submitted to FDA and Currently...
Source: globenewswire.com
Stay updated with breaking news from Tissue Based Product. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Receipt of FDA Warning Letter for AXIOFILL Classification; Not Related to Safety Request for Designation for AXIOFILL Submitted to FDA and Currently...